外科住院患者肌少症评估量表的构建与信效度分析<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2024.06.004

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1224 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To construct a risk assessment scale for sarcopenia in surgical inpatients and conduct reliability and validity tests, in order to provide a scientific and effective tool for assessing sarcopenia risk in surgical inpatients. 【Methods】On the basis of literature review, a pool of items for the scale was constructed, and the content system of the scale was determined through the Delphi method.The Analytic Hierarchy Process was used to determine the weights of scale items and assign values, forming a test scale. A test scale was used to assess the risk of sarcopenia in 239 patients admitted to the Hepatobiliary Department of Hunan Provincial People's Hospital, and the reliability and validity of the scale were tested. 【Results】A total of 11 experts were consulted through 2 rounds of correspondence, and their positive coefficients were all 100%. The authority coefficients of the experts were 0.88 and 0.89, respectively. The Kendall harmony coefficients were 0.138 and 0.153(P<0.001). A surgical inpatient sarcopenia risk assessment scale was constructed, including 5 primary indicators and 19 secondary indicators. The Cronbach's α coefficient of the scale was 0.829, and the content validity(I-CVI) of each item was 0.8-1.0, with a total content validity(S-CVI) of 0.99. Exploratory factor analysis extracted a total of 6 common factors, with a cumulative variance contribution rate of 63.784%.The area under the curve(AUC) of the ROC scale was 0.74(95%CI:0.666-0.813, P<0.001), the diagnostic threshold was 24 points, the sensitivity was 80%, and the specificity was 61.8%.【Conclusion】The constructed surgical inpatient sarcopenia risk assessment scale has certain scientific validity, practicality, and good reliability and validity, and can be used as a preliminary screening tool for clinical medical staff to evaluate the risk of sarcopenia in surgical inpatients.

Key words： Sarcopenia/DI Inpatients Risk Assessment

Received: 22 September 2023

PACS:

R685

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.06.004 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I6/813

[1] 杨云梅.老年肌肉衰减症研究新进展[J].中华危重症医学杂志(电子版),2018,11(5):289-294.
[2] 伍静薇,张莉,杨平.肝硬化伴肌少症病人运动干预研究进展[J].护理研究,2020,34(23):4221-4225.
[3] 王金霞,邹凤林,韩娟,等.胆管癌合并肌少症患者术后营养及运动干预[J].护理学杂志,2020,35(20):53-55.
[4] 姜珊,康琳,刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J].中华老年医学杂志,2020,39(4):373-376.
[5] 杨娟,李牧玲,李春梅,等.眼科住院患者跌倒风险评估量表的构建及初步验证[J].中华护理杂志,2022,57(1):67-73.
[6] 张阳,颜萍,赵萍,等.原发性肝癌患者肌少症发生情况及影响因素[J].华南预防医学,2020,46(2):175-177.
[7] 黄雨欣,许丽春,庄盼盼,等.维持性血液透析患者肌少症危险因素的Meta分析[J].护理学杂志,2022,37(13):17-21.
[8] 王付军.急性期慢阻肺患者肌少症的营养状况及与肺功能的关系[D].乌鲁木齐:新疆医科大学,2022.
[9] 蒋翠萍,邱婕萸真,陶晓明,等.中老年住院2型糖尿病患者肌少症发生率及相关危险因素分析[J].老年医学与保健,2021,27(6):1282-1286.
[10] ROQUEBERT Q, SICSIC J, SANTOS EGGIMANN B, et al.Frailty, sarcopenia and long care utilization in older populations: a systematic review[J].J Frailty Aging,2021,103: 272-280.
[11] GREGORY V K, DAMINK W M, NEUMANN P, et al. Sarcopenia and Cachexia-associated Risk in Surgery[J].Zentralblatt Fur Chirurgie,2021,1463: 277-282.
[12] 李海鹏,田鹏,璩航,等.SARC-F量表在快速简易诊断老年人肌肉衰减症研究中的应用[J].中国体育科技,2018,2:105-110.
[13] SATOSHI I, RYUTARO K, KANAKO I, et al. Verification of the predictive validity for mortality of the SARC-F questionnaire based on a meta-analysis[J].Aging Clin Exper Res,2021,334:835-842.
[14] CAO L,CHEN S,ZOU C, et al. A pilot study of the SARC-Fscale on screening sarcopenia and physical disability in the Chinese older people[J].J Nutr Health Aging,2014,18(3):277-283.